Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group
Abstract
Administration of high doses of respiratory syncytial virus immune globulin is a safe and effective means of preventing lower respiratory tract infection in infants and young children at high risk for this disease.
Keywords
immunization
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
logistic models
research support
non-u.s. gov't
u.s. gov't
female
male
Infant
newborn
P.H.S.
risk factors
Clinical Trial
Randomized Controlled Trial
Antibodies
Multicenter Study
immunoglobulins
intravenous / therapeutic use*
r c welliver
respiratory syncytial virus infections / immunology
respiratory syncytial virus infections / prevention & control*
passive*
respiratory syncytial viruses / immunology
intravenous / administration & dosage
heart defects
opportunistic infections / prevention & control*
viral / administration & dosage
premature
diseases / prevention & control*
j r groothuis
e a simoes
bronchopulmonary dysplasia / complications
congenital / complications
diseases / immunology
pmid:8413475
doi:10.1056/nejm199311183292102
Access
Citation
ID:
120499
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
120499
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet